HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women
Top Cited Papers
Open Access
- 3 November 2008
- Vol. 113 (S10) , 3036-3046
- https://doi.org/10.1002/cncr.23764
Abstract
Human papillomavirus (HPV) is a necessary cause of cervical cancer. In addition, on the basis of the fulfillment of a combination of viral as well as epidemiological criteria, it is currently accepted that a proportion of anal, oropharyngeal, vulvar, and vaginal cancers among women and anal, oropharyngeal, and penile cancers among men are etiologically related to HPV. At these noncervical sites with etiologic heterogeneity, HPV‐associated cancers represent a distinct clinicopathological entity, which is generally characterized by a younger age at onset, basaloid or warty histopathology, association with sexual behavior, and better prognosis, when compared with their HPV‐negative counterparts. Currently available estimates indicate that the number of HPV‐associated noncervical cancers diagnosed annually in the US roughly approximates the number of cervical cancers, with an equal number of noncervical cancers among men and women. Furthermore, whereas the incidence of cervical cancers has been decreasing over time, the incidence of anal and oropharyngeal cancers, for which there are no effective or widely used screening programs, has been increasing in the US. The efficacy of HPV vaccines in preventing infection at sites other than the cervix, vagina, and vulva should, therefore, be assessed (eg, oral and anal). Given that a substantial proportion of cervical cancers (approximately 70%) and an even greater proportion of HPV‐associated noncervical cancers (approximately 86% to 95%) are caused by HPV16 and 18 (HPV types that are targeted by the currently available vaccines), current HPV vaccines may hold great promise (provided equivalent efficacy at all relevant anatomic sites) in reducing the burden of HPV‐associated noncervical cancers, in addition to cervical cancers. Cancer 2008;113:(10 suppl):3036–46. Published 2008 by the American Cancer Society.Keywords
This publication has 69 references indexed in Scilit:
- Understanding the burden of human papillomavirus-associated anal cancers in the USCancer, 2008
- Burden of invasive squamous cell carcinoma of the penis in the United States, 1998-2003Cancer, 2008
- Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical TrialJNCI Journal of the National Cancer Institute, 2008
- Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccinationPopulation Health Metrics, 2007
- Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysisThe Lancet Infectious Diseases, 2007
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Comprehensive analysis of 130 multicentric intraepithelial female lower genital tract lesions by HPV typing and p16 expression profileZeitschrift für Krebsforschung und Klinische Onkologie, 2006
- Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital wartsMedical Microbiology and Immunology, 2003
- Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysisBritish Journal of Cancer, 2003
- Sexual Practices, Sexually Transmitted Diseases, and the Incidence of Anal CancerNew England Journal of Medicine, 1987